Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia
Status:
Terminated
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
To document effectiveness, safety, and tolerability of donepezil in patients with mixed
AD/VaD, and to further document the effectiveness, safety, and tolerability of donepezil in
patients with VaD. The effects of donepezil on executive functioning, behavior, general
cognition, ADLs and global functioning will be assessed.